{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:56:09Z","timestamp":1740135369224,"version":"3.37.3"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32-AR076951","K23-HL148539","K24-AR078950"],"award-info":[{"award-number":["T32-AR076951","K23-HL148539","K24-AR078950"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"DOI":"10.1186\/s12887-024-05206-y","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T09:05:00Z","timestamp":1730970300000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of chronic opioid use on acute health care utilization in children with IBD and arthritis: a retrospective cohort study"],"prefix":"10.1186","volume":"24","author":[{"given":"Atiye O. Bilgic","family":"Dagci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunzhou","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joyce C.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew B.","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela F.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,7]]},"reference":[{"issue":"4","key":"5206_CR1","first-page":"619","volume":"26","author":"Y Ye","year":"2020","unstructured":"Ye Y, Manne S, Treem WR, Bennett D. Prevalence of inflammatory Bowel Disease in Pediatric and adult populations: recent estimates from large National databases in the United States, 2007\u20132016. Inflamm Bowel Dis. 2020;26(4):619\u201325.","journal-title":"Inflamm Bowel Dis"},{"key":"5206_CR2","doi-asserted-by":"crossref","unstructured":"Bilgic Dagci AO, Chang JC, Xiao R, Grossman AB, Weiss PF. Opioid use in children with inflammatory bowel disease-related arthritis. Clin Exp Rheumatol. 2023.","DOI":"10.55563\/clinexprheumatol\/3bu1sf"},{"issue":"5","key":"5206_CR3","first-page":"1045","volume":"40","author":"AO Bilgic Dagci","year":"2022","unstructured":"Bilgic Dagci AO, Chang JC, Brandon TG, Goheer HE, Weiss PF. Clinical features, treatment patterns and short-term outcomes of children with inflammatory bowel disease evaluated in rheumatology clinic. Clin Exp Rheumatol. 2022;40(5):1045\u201351.","journal-title":"Clin Exp Rheumatol"},{"key":"5206_CR4","doi-asserted-by":"crossref","unstructured":"Horton DB, Sherry DD, Baldassano RN, Weiss PF. Enthesitis is an Extraintestinal Manifestation of Pediatric Inflammatory Bowel Disease. Ann Paediatr Rheumatol. 2012;1(4).","DOI":"10.5455\/apr.102920121510"},{"issue":"5","key":"5206_CR5","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.cgh.2020.08.041","volume":"19","author":"B Niccum","year":"2021","unstructured":"Niccum B, Moninuola O, Miller K, Khalili H. Opioid use among patients with inflammatory bowel disease: a systematic review and Meta-analysis. Clin Gastroenterol Hepatol. 2021;19(5):895\u2013e9074.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"5206_CR6","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/ajg.2018.27","volume":"113","author":"GR Lichtenstein","year":"2018","unstructured":"Lichtenstein GR, Loftus EV, Isaacs KL, Regueiro MD, Gerson LB, Sands BE. ACG Clinical Guideline: management of Crohn\u2019s disease in adults. Am J Gastroenterol. 2018;113(4):481\u2013517.","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"5206_CR7","doi-asserted-by":"publisher","first-page":"599","DOI":"10.36076\/ppj.2015\/18\/599","volume":"18","author":"DG Ribaldone","year":"2015","unstructured":"Ribaldone DG, Fagoonee S, Astegiano M, De Angelis C, Smedile A, Caviglia GP, et al. Coxib\u2019s safety in patients with inflammatory Bowel diseases: a Meta-analysis. Pain Physician. 2015;18(6):599\u2013607.","journal-title":"Pain Physician"},{"issue":"5","key":"5206_CR8","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.cgh.2006.03.002","volume":"4","author":"GR Lichtenstein","year":"2006","unstructured":"Lichtenstein GR, Feagan BG, Cohen RD, Salzberg BA, Diamond RH, Chen DM, et al. Serious infections and mortality in association with therapies for Crohn\u2019s disease: TREAT registry. Clin Gastroenterol Hepatol. 2006;4(5):621\u201330.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"5206_CR9","first-page":"1030","volume":"12","author":"S Cohen-Mekelburg","year":"2018","unstructured":"Cohen-Mekelburg S, Rosenblatt R, Gold S, Burakoff R, Waljee AK, Saini S, et al. The impact of opioid epidemic Trends on Hospitalised Inflammatory Bowel Disease patients. J Crohns Colitis. 2018;12(9):1030\u20135.","journal-title":"J Crohns Colitis"},{"issue":"10","key":"5206_CR10","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1093\/ibd\/izy222","volume":"24","author":"AA Wren","year":"2018","unstructured":"Wren AA, Bensen R, Sceats L, Dehghan M, Yu H, Wong JJ, et al. Starting Young: Trends in Opioid Therapy among US adolescents and young adults with inflammatory bowel disease in the Truven MarketScan Database between 2007 and 2015. Inflamm Bowel Dis. 2018;24(10):2093\u2013103.","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"5206_CR11","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.cgh.2017.10.022","volume":"16","author":"NE Burr","year":"2018","unstructured":"Burr NE, Smith C, West R, Hull MA, Subramanian V. Increasing prescription of opiates and mortality in patients with inflammatory bowel diseases in England. Clin Gastroenterol Hepatol. 2018;16(4):534\u2013e416.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"5206_CR12","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1093\/ibd\/izac021","volume":"28","author":"JL Sheehan","year":"2022","unstructured":"Sheehan JL, Jacob J, Berinstein EM, Greene-Higgs L, Steiner CA, Berry SK, et al. The Relationship between Opioid Use and Healthcare utilization in patients with inflammatory bowel disease: a systematic review and Meta-analysis. Inflamm Bowel Dis. 2022;28(12):1904\u201314.","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"5206_CR13","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.cgh.2016.09.012","volume":"15","author":"J Limsrivilai","year":"2017","unstructured":"Limsrivilai J, Stidham RW, Govani SM, Waljee AK, Huang W, Higgins PD. Factors that Predict High Health Care utilization and costs for patients with inflammatory Bowel diseases. Clin Gastroenterol Hepatol. 2017;15(3):385\u2013e922.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"5206_CR14","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1097\/MIB.0000000000000763","volume":"22","author":"B Click","year":"2016","unstructured":"Click B, Ramos Rivers C, Koutroubakis IE, Babichenko D, Anderson AM, Hashash JG, et al. Demographic and clinical predictors of High Healthcare Use in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2016;22(6):1442\u20139.","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"5206_CR15","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/MIB.0000000000000977","volume":"23","author":"BB Rao","year":"2017","unstructured":"Rao BB, Click BH, Koutroubakis IE, Ramos Rivers C, Regueiro M, Swoger J, et al. The cost of Crohn\u2019s Disease: Varied Health Care expenditure patterns across distinct Disease trajectories. Inflamm Bowel Dis. 2017;23(1):107\u201315.","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"5206_CR16","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/pm\/pny116","volume":"20","author":"S Gmuca","year":"2019","unstructured":"Gmuca S, Xiao R, Weiss PF, Sherry DD, Knight AM, Gerber JS. Opioid prescribing and polypharmacy in children with Chronic Musculoskeletal Pain. Pain Med. 2019;20(3):495\u2013503.","journal-title":"Pain Med"},{"issue":"3","key":"5206_CR17","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1093\/ibd\/izab074","volume":"28","author":"S Singh","year":"2022","unstructured":"Singh S, Qian AS, Nguyen NH, Ho SKM, Luo J, Jairath V, et al. Trends in U.S. Health Care spending on inflammatory Bowel diseases, 1996\u20132016. Inflamm Bowel Dis. 2022;28(3):364\u201372.","journal-title":"Inflamm Bowel Dis"},{"issue":"11","key":"5206_CR18","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1002\/pds.1824","volume":"18","author":"L Liu","year":"2009","unstructured":"Liu L, Allison JE, Herrinton LJ. Validity of computerized diagnoses, procedures, and drugs for inflammatory bowel disease in a northern California managed care organization. Pharmacoepidemiol Drug Saf. 2009;18(11):1086\u201393.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"5206_CR19","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/acr.24100","volume":"73","author":"LH Buckley","year":"2021","unstructured":"Buckley LH, Xiao R, Perman MJ, Grossman AB, Weiss PF. Psoriasis Associated with Tumor necrosis factor inhibitors in Children with Inflammatory diseases. Arthritis Care Res (Hoboken). 2021;73(2):215\u201320.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"8","key":"5206_CR20","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1002\/art.34458","volume":"64","author":"T Beukelman","year":"2012","unstructured":"Beukelman T, Xie F, Chen L, Baddley JW, Delzell E, Grijalva CG, et al. Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment. Arthritis Rheum. 2012;64(8):2773\u201380.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"5206_CR21","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1177\/2475530318799072","volume":"3","author":"TG Brandon","year":"2018","unstructured":"Brandon TG, Manos CK, Xiao R, Ogdie A, Weiss PF. Pediatric psoriatic arthritis: a population-based cohort study of risk factors for onset and subsequent risk of inflammatory comorbidities. J Psoriasis Psoriatic Arthritis. 2018;3(4):131\u20136.","journal-title":"J Psoriasis Psoriatic Arthritis"},{"issue":"9","key":"5206_CR22","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1002\/art.40152","volume":"69","author":"JR Curtis","year":"2017","unstructured":"Curtis JR, Xie F, Smith C, Saag KG, Chen L, Beukelman T, et al. Changing trends in Opioid Use among patients with rheumatoid arthritis in the United States. Arthritis Rheumatol. 2017;69(9):1733\u201340.","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"5206_CR23","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3414\/ME9241","volume":"48","author":"M Wolkewitz","year":"2009","unstructured":"Wolkewitz M, Beyersmann J, Gastmeier P, Schumacher M. Efficient risk set sampling when a time-dependent exposure is present: matching for time to exposure versus exposure density sampling. Methods Inf Med. 2009;48(5):438\u201343.","journal-title":"Methods Inf Med"},{"issue":"1","key":"5206_CR24","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12877-017-0621-2","volume":"17","author":"N Masnoon","year":"2017","unstructured":"Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17(1):230.","journal-title":"BMC Geriatr"},{"issue":"6","key":"5206_CR25","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1097\/MIB.0000000000001087","volume":"23","author":"NJ Pauly","year":"2017","unstructured":"Pauly NJ, Michailidis L, Kindred MG, Flomenhoft D, Lofwall MR, Walsh SL, et al. Predictors of chronic opioid use in newly diagnosed Crohn\u2019s Disease. Inflamm Bowel Dis. 2017;23(6):1004\u201310.","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"5206_CR26","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/apt.15023","volume":"49","author":"M Noureldin","year":"2019","unstructured":"Noureldin M, Higgins PDR, Govani SM, Cohen-Mekelburg S, Kenney BC, Stidham RW, et al. Incidence and predictors of new persistent opioid use following inflammatory bowel disease flares treated with oral corticosteroids. Aliment Pharmacol Ther. 2019;49(1):74\u201383.","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"5206_CR27","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1111\/apt.16269","volume":"53","author":"C Rhudy","year":"2021","unstructured":"Rhudy C, Perry CL, Singleton M, Talbert J, Barrett TA. Chronic opioid use is associated with early biologic discontinuation in inflammatory bowel disease. Aliment Pharmacol Ther. 2021;53(6):704\u201311.","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"5206_CR28","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/art.40789","volume":"71","author":"YC Lee","year":"2019","unstructured":"Lee YC, Kremer J, Guan H, Greenberg J, Solomon DH. Chronic opioid use in rheumatoid arthritis: prevalence and predictors. Arthritis Rheumatol. 2019;71(5):670\u20137.","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"5206_CR29","doi-asserted-by":"publisher","first-page":"otab021","DOI":"10.1093\/crocol\/otab021","volume":"3","author":"EM Szigethy","year":"2021","unstructured":"Szigethy EM, Murphy SM, Ehrlich OG, Heller CA, Engel-Nitz NM, Meadows P, et al. Opioid Use Associated with higher costs among patients with inflammatory bowel disease. Crohns Colitis 360. 2021;3(2):otab021.","journal-title":"Crohns Colitis 360"},{"issue":"2","key":"5206_CR30","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1572-0241.2006.00384.x","volume":"101","author":"Y El Miedany","year":"2006","unstructured":"El Miedany Y, Youssef S, Ahmed I, El Gaafary M. The gastrointestinal safety and effect on disease activity of etoricoxib, a selective cox-2 inhibitor in inflammatory bowel diseases. Am J Gastroenterol. 2006;101(2):311\u20137.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"5206_CR31","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.cgh.2005.12.002","volume":"4","author":"WJ Sandborn","year":"2006","unstructured":"Sandborn WJ, Stenson WF, Brynskov J, Lorenz RG, Steidle GM, Robbins JL, et al. Safety of celecoxib in patients with ulcerative colitis in remission: a randomized, placebo-controlled, pilot study. Clin Gastroenterol Hepatol. 2006;4(2):203\u201311.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5206_CR32","doi-asserted-by":"crossref","unstructured":"Miao XP, Li JS, Ouyang Q, Hu RW, Zhang Y, Li HY. Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease. Cochrane Database Syst Rev. 2014(10):Cd007744.","DOI":"10.1002\/14651858.CD007744.pub2"},{"issue":"10","key":"5206_CR33","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1016\/j.cgh.2018.05.017","volume":"16","author":"JR Goldsmith","year":"2018","unstructured":"Goldsmith JR, Sartor RB. Opioid toxicity in inflammatory bowel disease patients likely includes direct Enterocyte effects that Exacerbate Disease. Clin Gastroenterol Hepatol. 2018;16(10):1679\u201380.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"5206_CR34","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.neuroscience.2005.06.003","volume":"135","author":"HY Wang","year":"2005","unstructured":"Wang HY, Friedman E, Olmstead MC, Burns LH. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and gbetagamma signaling. Neuroscience. 2005;135(1):247\u201361.","journal-title":"Neuroscience"},{"issue":"5","key":"5206_CR35","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0165-6147(90)90112-L","volume":"11","author":"PJ Barnes","year":"1990","unstructured":"Barnes PJ, Belvisi MG, Rogers DF. Modulation of neurogenic inflammation: novel approaches to inflammatory disease. Trends Pharmacol Sci. 1990;11(5):185\u20139.","journal-title":"Trends Pharmacol Sci"},{"key":"5206_CR36","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1742-2094-7-37","volume":"7","author":"SE Lakhan","year":"2010","unstructured":"Lakhan SE, Kirchgessner A. Neuroinflammation in inflammatory bowel disease. J Neuroinflammation. 2010;7:37.","journal-title":"J Neuroinflammation"},{"issue":"10","key":"5206_CR37","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/s11894-014-0410-4","volume":"16","author":"E Szigethy","year":"2014","unstructured":"Szigethy E, Schwartz M, Drossman D. Narcotic bowel syndrome and opioid-induced constipation. Curr Gastroenterol Rep. 2014;16(10):410.","journal-title":"Curr Gastroenterol Rep"},{"issue":"7","key":"5206_CR38","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/RHU.0b013e31826d2663","volume":"18","author":"V Vijayan","year":"2012","unstructured":"Vijayan V, Moran R, Elder ME, Sukumaran S. Acute-onset opioid-induced hyperalgesia in a child with juvenile idiopathic arthritis. J Clin Rheumatol. 2012;18(7):349\u201351.","journal-title":"J Clin Rheumatol"},{"issue":"6","key":"5206_CR39","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1097\/MIB.0000000000001121","volume":"23","author":"EL Barnes","year":"2017","unstructured":"Barnes EL, Kochar B, Long MD, Kappelman MD, Martin CF, Korzenik JR, et al. Modifiable risk factors for Hospital Readmission among patients with inflammatory bowel disease in a Nationwide Database. Inflamm Bowel Dis. 2017;23(6):875\u201381.","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"5206_CR40","first-page":"40","volume":"27","author":"E Szigethy","year":"2021","unstructured":"Szigethy E, Murphy SM, Ehrlich OG, Engel-Nitz NM, Heller CA, Henrichsen K, et al. Mental Health Costs Inflamm Bowel Dis Inflamm Bowel Dis. 2021;27(1):40\u20138.","journal-title":"Mental Health Costs Inflamm Bowel Dis Inflamm Bowel Dis"},{"issue":"10","key":"5206_CR41","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1111\/j.1365-2036.2005.02429.x","volume":"21","author":"RK Cross","year":"2005","unstructured":"Cross RK, Wilson KT, Binion DG. Polypharmacy and Crohn\u2019s disease. Aliment Pharmacol Ther. 2005;21(10):1211\u20136.","journal-title":"Aliment Pharmacol Ther"},{"issue":"13","key":"5206_CR42","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1097\/01.MIB.0000435442.07237.a4","volume":"19","author":"JP Buckley","year":"2013","unstructured":"Buckley JP, Kappelman MD, Allen JK, Van Meter SA, Cook SF. The burden of comedication among patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013;19(13):2725\u201336.","journal-title":"Inflamm Bowel Dis"},{"issue":"10","key":"5206_CR43","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1111\/j.1572-0241.2005.00256.x","volume":"100","author":"RK Cross","year":"2005","unstructured":"Cross RK, Wilson KT, Binion DG. Narcotic use in patients with Crohn\u2019s disease. Am J Gastroenterol. 2005;100(10):2225\u20139.","journal-title":"Am J Gastroenterol"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-024-05206-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-024-05206-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-024-05206-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T09:12:08Z","timestamp":1730970728000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-024-05206-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,7]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5206"],"URL":"https:\/\/doi.org\/10.1186\/s12887-024-05206-y","relation":{},"ISSN":["1471-2431"],"issn-type":[{"type":"electronic","value":"1471-2431"}],"subject":[],"published":{"date-parts":[[2024,11,7]]},"assertion":[{"value":"26 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Children\u2019s Hospital of Philadelphia (CHOP) Institutional Review Board (IRB) reviewed this study and granted a waiver of consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"711"}}